[Proton magnetic resonance spectroscopy in the evaluation of cognitive disturbances]
Henrik Kahr Mathiesen1, Annette Skraep Nielsen, Kirsten Nielsen
1H:S Hvidovre Hospital, MR-afdelingen, Hvidovre. henrikm@drcmr.dk
Ugeskrift for Laeger
|January 27, 2006
Abstract:
Magnetic resonance spectroscopy can detect metabolic changes in the brain, including changes in N-acetyl aspartate, a metabolite generally believed to be a marker of neuronal integrity. The correlations between metabolic changes and cognitive status in normal subjects and in a range of neurological and psychiatric disorders are reviewed. Magnetic resonance spectroscopy seems to be a way to monitor the efficacy of existing and new treatments to prevent the development of cognitive deficits in a number of diseases.


